X
Get new exclusive access to healthcare business reports & breaking news
Biotech
Mission Therapeutics (“Mission”), a drug creator company focused on selectively targeting deubiquitylating enzymes (DUBs) and Chicago-based AbbVie (“AbbVie”), ...
Verily, Alphabet’s life sciences subdivision, has announced that it is shelving a project to develop a contact lens ...
On November 14th, at the 47th American Association of Gynecologic Laparoscopists (AAGL) Global Congress on Minimally Invasive Gynecology ...
On November 13th, Chicago-based AbbVie, a research-based global biopharmaceutical company, released new findings on its pan-genotypic chronic hepatitis C ...
Northwestern Medicine scientists made a discovery that could pave the way for future therapies to treat glaucoma, a ...
Funding for European biotech firms is expected to reach $8 billion this year, a new record for financing, ...
According to Renaissance Capital, the IPO assigns Allogene a fully diluted market value of $2.1 billion and an ...
A small device made by Chicago-based Abbott Laboratories can greatly reduce death rates in patients with severe heart ...
A University of Chicago biotech startup was awarded a $2.3 million grant that would speed up the development ...
